Can these top-performing funds help you to achieve financial independence?

These two funds have produced huge returns for investors and it could be worth buying-in to profit from steady gains.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Pantheon International (LSE: PIN) flies under the radar of most investors, but I believe that the fund is worth a closer look. 

Over the past five years, the fund, which invests in private equity assets around the world, has produced a return for investors of 134% for investors excluding dividends, outperforming the FTSE 100 by 110%.

And unlike other shares, which are generally volatile, Pantheon has produced these returns with little volatility; the shares have marched steadily higher over the past 10 years despite the wider market turbulence.

Underlying asset value growth 

Today the private equity manager reported yet another healthy increase in the underlying asset value of its portfolio. Pantheon’s net asset value per share at the end of August hit 2,303p, an increase of 131p, or 6% from the NAV reported at the end of July.

The fund manager’s portfolio generated net cash of £22.5m during the month and completed six new investments amounting to £38m. This included a £13.7m secondary investment in a portfolio of five energy and transport assets, and an £11.4m secondary investment in an educational business with an established footprint in Europe, Latin America and Africa.

Other investments included a £3.1m allocation alongside BC Partners in PetSmart, a specialty pet retailer with over 1,500 stores in North America.

Time to buy? 

Pantheon has been able to generate such steady returns for investors over the years because the firm invests in private assets, which are not correlated with the stock market. These are growing businesses with a huge runway for expansion ahead of them allowing Pantheon and its investors to reap enormous rewards. 

Since inception, the firm has grown its net asset value at a rate of 11.9% per annum.  However, at the time of writing the shares are trading at a discount of 28% to the NAV per share. As long as the company can continue to grow its asset value at a double-digit rate every year, I believe this is a very attractive investment opportunity for investors. 

Cash cow

Electra Private Equity (LSE: ELTA) operates a similar business model to Pantheon and has produced similar returns for investors over the past decade. For the 10 years to March 31, Electra has grown its NAV by 230% and seen its shares rise by 237% with an annualised return on equity of 13% over the decade. Earlier this year the investment trust decided to return £1bn to investors via a special dividend after a decade of steady returns.

Over the long term, Electra’s management is targeting annualised NAV growth of between 10% and 15%, which is clearly a comfortable range based on the performance of the past 10 years. 

I believe that the firm can continue to churn out these impressive returns as the business is currently managed by Edward Bramson, whose Sherborne Investors investment vehicle is the biggest shareholder in Electra. Sherborne fought a long and bitter campaign to get Bramson on Electra’s board as part of a plan to overhaul the private equity firm. Sherborne’s team believes there’s more value to be unlocked from Electra’s portfolio, implying that the trust will see further growth in its NAV during the years ahead. 

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »

Investing Articles

3 top Vanguard ETFs to consider for an ISA or SIPP in 2026

Edward Sheldon believes that these three Vanguard ETFs could be solid investments for a pension (SIPP) or investment account in…

Read more »

Investing Articles

5 growth stocks on Dr James Fox’s watchlist for 2026

Dr James Fox believes these UK and US growth stocks are worth considering as he looks to outperform the stock…

Read more »